Antimicrobial Copper Surfaces - Clinical and Laboratory Performance

Hospital-acquired infections place a substantial burden on healthcare systems. Patients that incur an HAI average 19.2 more days in the hospital and $43,000 more in medical bills. With the passage of the Patient Protection and Affordable Care Act, the federal government adopted a system to boost Medicare payments to hospitals that reduce HAI’s.  Antimicrobial Copper environmental surfaces are available to help hospitals fight the bacteria that cause HAI’s.  They are the only surfaces registered with the Environmental Protection Agency as antimicrobial public health products. Join us to learn how your hospital can benefit from Antimicrobial Copper environmental surfaces.

In this webinar, you'll learn:

1. Laboratory and clinical research on the intrinsic antimicrobial properties of  copper
2. The benefits of incorporating Antimicrobial Copper as a  supplement to your hygienic practices
3. Significance of bio-load reduction in the healthcare environment
4. Methods of proper use and care for Antimicrobial Copper surfaces to maintain optimal performance

Sponsored by:

Speaker: Dr. Harold T. Michels, PhD.

Dr. Michels is Senior Vice President of Technology and Technical Services of the Copper Development Association, where he is responsible for the management of market development and research programs including the antimicrobial copper initiative.  He holds a Bachelor of Science in Mechanical Engineering from The City College of New York, a Master of Science in Metallurgy and a Ph.D. in Materials Science from New York University and is a licensed Professional Engineer in New York and California. Harold is a highly experienced metallurgist with over 40 years of experience in non-ferrous metals industries. He holds several U.S. patents and has authored and co-authored numerous technical papers including papers relating to the antimicrobial properties of copper, an intrinsic property which has never been fully employed for the benefit of society or fully understood. He is one of the Principal Investigators of the clinical trials underway at three major hospitals investigating copper’s ability to reduce biological surface contamination in Intensive Care Unit rooms.